US 8877213
Live attenuated Leishmania vaccines
granted A61KA61K2039/522A61K39/008
Quick answer
US patent 8877213 (Live attenuated Leishmania vaccines) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2039/522, A61K39/008, A61P, A61P33/02